Sun Pharma Investments

Sun Pharma has invested in 5 companies and its latest investment was HaystackAnalytics on Jul 09, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

HaystackAnalytics is an India-based healthtech company that develops clinical genomics-focused, personalized diagnostic systems for clinicians, hospitals, and medical labs.
$4M
Jul 09, 2024
-
Lyndra is a Massachusetts-based biopharmaceutical company that researches and develops oral therapies for the treatment of schizophrenia and central nervous system disorders.
$122.7M
Dec 14, 2023
-
Agatsa is an India-based medical device company that designs and manufactures technology-integrated ECG monitoring devices for healthcare professionals.
-
Feb 20, 2023
-
Krystal is a Pennsylvania-based biotechnology company that discovers and develops genetic medicines for patients with skin diseases.
$11.3M
Aug 07, 2017
-
Enceladus develops liposomal formulations of corticosteroids to treat inflammatory and autoimmune diseases and cancer.
-
Oct 20, 2015
-

Frequently Asked Questions about Sun Pharma

  1. What is Sun Pharma investing in?

    Sun Pharma has invested in 5 companies including HaystackAnalytics, Lyndra and Agatsa
  2. What company did Sun Pharma invest in?

    Sun Pharma invested in a total 5 companies including HaystackAnalytics, Lyndra and Agatsa
  1. What are the top 5 investments by Sun Pharma?

    The top companies in which Sun Pharma invested are HaystackAnalytics, Lyndra, Agatsa, Krystal and Enceladus Pharmaceuticals